FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Animals (Basel) / The Influence of Diet Change and Oral Metformin on Blood Glu...
Animals : an open access journal from MDPI2021; 11(4); 976; doi: 10.3390/ani11040976

The Influence of Diet Change and Oral Metformin on Blood Glucose Regulation and the Fecal Microbiota of Healthy Horses.

Abstract: Common treatments for Equine Metabolic Syndrome (EMS) and associated conditions include removal from pasture and adoption of an all-hay diet. Pharmacological treatments for EMS include metformin, a biguanide antihyperglycemic agent also administered to people to help improve glucose tolerance and insulin sensitivity. Both treatments may work, at least partially, through the gut microbiota, yet little is known regarding these effects in the equine host. To determine the influence on the fecal microbiota of this diet change and administration of metformin, six healthy horses were removed from pasture and switched to an all-hay diet, with four of those horses also receiving oral metformin for seven days. Control horses ( = 24) remaining on pasture and receiving no metformin were sampled at the beginning and end of one week. All samples were subjected to 16S rRNA sequencing, and horses undergoing the diet change were subjected to an oral sugar test twice, one week apart. Characteristic changes in the microbiota following diet change included the significant expansion of the phylum Kiritimatiellaeota. As Kiritimatiellaeota are related to Verrucomicrobia, found to expand in the microbiota of mice and humans in response to metformin, this taxon may represent the cognate microbes in equine hosts.
Get Full Text
Publication Date: 2021-04-01 PubMed ID: 33915682PubMed Central: PMC8065426DOI: 10.3390/ani11040976Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores how changes in diet and use of metformin, a medication to manage blood sugar, impact blood glucose regulation and the composition of gut bacteria in healthy horses. The study’s findings may shed light on ways to manage equine metabolic syndrome.

Background

  • The central aspect of this research revolves around Equine Metabolic Syndrome (EMS), a health condition in horses that is often addressed by changing the animal’s diet from pasture grazing to a hay-based diet.
  • Another common treatment approach is the administration of metformin, a drug typically used to manage glucose levels and increase insulin sensitivity, more often seen in human diabetes treatment. The theory is that both these treatments can exert their beneficial effects through alterations of the gut microbiota. However, the underlying impacts of these treatments on gut microbiota in horses are not well understood.

Methods

  • In this research, the authors sought to investigate these effects by studying six healthy horses that were switched from a grazing pasture to a hay-based diet. Four of these horses also received oral metformin for a week.
  • A control group of horses (n=24) that remained on pasture and did not receive metformin were also studied. Samples were collected from each horse at the start and end of the week. The horses undergoing the dietary shift were also subjected to an oral sugar test twice during the week, each test a week apart.
  • All samples were tested using 16S rRNA sequencing to understand the impact on the microbiota.

Findings

  • Results of the study showed that the changes made to the horses’ diet and the introduction of metformin significantly expanded the presence of the bacterial group Kiritimatiellaeota in the gut microbiota.
  • The importance of this finding lies in the understanding that Kiritimatiellaeota are related to Verrucomicrobia, another group of bacteria known to multiply in response to metformin treatment in mice and humans.
  • Hence, it can be inferred that Kiritimatiellaeota could play a similar role in the equine system, potentially mediating positive metabolic changes induced by diet management and metformin therapy in horses with EMS.

Cite This Article

APA
Ericsson AC, Johnson PJ, Gieche LM, Zobrist C, Bucy K, Townsend KS, Martin LM, LaCarrubba AM. (2021). The Influence of Diet Change and Oral Metformin on Blood Glucose Regulation and the Fecal Microbiota of Healthy Horses. Animals (Basel), 11(4), 976. https://doi.org/10.3390/ani11040976

Publication

Animals : an open access journal from MDPI
ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 11
Issue: 4
PII: 976

Researcher Affiliations

Ericsson, Aaron C
  • University of Missouri Metagenomics Center, Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, MO 65201, USA.
Johnson, Philip J
  • Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.
Gieche, Lyndsy M
  • College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.
Zobrist, Chelsea
  • College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.
Bucy, Katie
  • Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.
Townsend, Kile S
  • Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.
Martin, Lynn M
  • Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.
LaCarrubba, Alison M
  • Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.

Conflict of Interest Statement

The authors have no conflict or competing interest.

References

This article includes 43 references
  1. Frank N, Geor RJ, Bailey SR, Durham AE, Johnson PJ. Equine metabolic syndrome.. J Vet Intern Med 2010 May-Jun;24(3):467-75.
    doi: 10.1111/j.1939-1676.2010.0503.xpubmed: 20384947google scholar: lookup
  2. Johnson PJ. The equine metabolic syndrome peripheral Cushing's syndrome.. Vet Clin North Am Equine Pract 2002 Aug;18(2):271-93.
    doi: 10.1016/S0749-0739(02)00006-8pubmed: 15635908google scholar: lookup
  3. Muno J, Gallatin L, Geor RJ, Anderson GA, Hinchcliff KW. Prevalence and risk factors for hyperinsulinemia in clinically normal horses in central Ohio.. J. Vet. Intern. Med. 2009;23:721.
  4. Pleasant RS, Suagee JK, Thatcher CD, Elvinger F, Geor RJ. Adiposity, plasma insulin, leptin, lipids, and oxidative stress in mature light breed horses.. J Vet Intern Med 2013 May-Jun;27(3):576-82.
    doi: 10.1111/jvim.12056pubmed: 23517373google scholar: lookup
  5. Morgan RA, McGowan TW, McGowan CM. Prevalence and risk factors for hyperinsulinaemia in ponies in Queensland, Australia.. Aust Vet J 2014 Apr;92(4):101-6.
    doi: 10.1111/avj.12159pubmed: 24673135google scholar: lookup
  6. Sessions-Bresnahan DR, Carnevale EM. The effect of equine metabolic syndrome on the ovarian follicular environment.. J Anim Sci 2014 Apr;92(4):1485-94.
    doi: 10.2527/jas.2013-7275pubmed: 24663160google scholar: lookup
  7. Durham AE, Frank N, McGowan CM, Menzies-Gow NJ, Roelfsema E, Vervuert I, Feige K, Fey K. ECEIM consensus statement on equine metabolic syndrome.. J Vet Intern Med 2019 Mar;33(2):335-349.
    doi: 10.1111/jvim.15423pmc: PMC6430910pubmed: 30724412google scholar: lookup
  8. Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, Brett CM, Giacomini KM. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.. J Clin Invest 2007 May;117(5):1422-31.
    doi: 10.1172/JCI30558pmc: PMC1857259pubmed: 17476361google scholar: lookup
  9. Wang DS, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, Sugiyama Y. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.. J Pharmacol Exp Ther 2002 Aug;302(2):510-5.
    doi: 10.1124/jpet.102.034140pubmed: 12130709google scholar: lookup
  10. de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V, Velásquez-Mejía EP, Carmona JA, Abad JM, Escobar JS. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.. Diabetes Care 2017 Jan;40(1):54-62.
    doi: 10.2337/dc16-1324pubmed: 27999002google scholar: lookup
  11. Shin NR, Lee JC, Lee HY, Kim MS, Whon TW, Lee MS, Bae JW. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.. Gut 2014 May;63(5):727-35.
    doi: 10.1136/gutjnl-2012-303839pubmed: 23804561google scholar: lookup
  12. Sun L, Xie C, Wang G, Wu Y, Wu Q, Wang X, Liu J, Deng Y, Xia J, Chen B, Zhang S, Yun C, Lian G, Zhang X, Zhang H, Bisson WH, Shi J, Gao X, Ge P, Liu C, Krausz KW, Nichols RG, Cai J, Rimal B, Patterson AD, Wang X, Gonzalez FJ, Jiang C. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.. Nat Med 2018 Dec;24(12):1919-1929.
    doi: 10.1038/s41591-018-0222-4pmc: PMC6479226pubmed: 30397356google scholar: lookup
  13. Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, Ståhlman M, Olsson LM, Serino M, Planas-Fèlix M, Xifra G, Mercader JM, Torrents D, Burcelin R, Ricart W, Perkins R, Fernàndez-Real JM, Bäckhed F. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.. Nat Med 2017 Jul;23(7):850-858.
    doi: 10.1038/nm.4345pubmed: 28530702google scholar: lookup
  14. Lee H, Lee Y, Kim J, An J, Lee S, Kong H, Song Y, Lee CK, Kim K. Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice.. Gut Microbes 2018 Mar 4;9(2):155-165.
    doi: 10.1080/19490976.2017.1405209pmc: PMC5989809pubmed: 29157127google scholar: lookup
  15. Zhang X, Zhao Y, Xu J, Xue Z, Zhang M, Pang X, Zhang X, Zhao L. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats.. Sci Rep 2015 Sep 23;5:14405.
    doi: 10.1038/srep14405pmc: PMC4585776pubmed: 26396057google scholar: lookup
  16. Ericsson AC, Johnson PJ, Lopes MA, Perry SC, Lanter HR. A Microbiological Map of the Healthy Equine Gastrointestinal Tract.. PLoS One 2016;11(11):e0166523.
    doi: 10.1371/journal.pone.0166523pmc: PMC5112786pubmed: 27846295google scholar: lookup
  17. Elzinga SE, Weese JS, Adams AA. Comparison of the fecal microbiota in horses with equine metabolic syndrome and metabolically normal controls fed a similar all-forage diet.. J. Equine Vet. Sci. 2016;44:9–16.
    doi: 10.1016/j.jevs.2016.05.010google scholar: lookup
  18. Tinworth KD, Boston RC, Harris PA, Sillence MN, Raidal SL, Noble GK. The effect of oral metformin on insulin sensitivity in insulin-resistant ponies.. Vet J 2012 Jan;191(1):79-84.
    doi: 10.1016/j.tvjl.2011.01.015pubmed: 21349749google scholar: lookup
  19. Vick MM, Sessions DR, Murphy BA, Kennedy EL, Reedy SE, Fitzgerald BP. Obesity is associated with altered metabolic and reproductive activity in the mare: effects of metformin on insulin sensitivity and reproductive cyclicity.. Reprod Fertil Dev 2006;18(6):609-17.
    doi: 10.1071/RD06016pubmed: 16930507google scholar: lookup
  20. Durham AE, Rendle DI, Newton JE. The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance.. Equine Vet J 2008 Jul;40(5):493-500.
    doi: 10.2746/042516408X273648pubmed: 18482898google scholar: lookup
  21. Rendle DI, Rutledge F, Hughes KJ, Heller J, Durham AE. Effects of metformin hydrochloride on blood glucose and insulin responses to oral dextrose in horses.. Equine Vet J 2013 Nov;45(6):751-4.
    doi: 10.1111/evj.12068pubmed: 23600690google scholar: lookup
  22. Tinworth KD, Edwards S, Noble GK, Harris PA, Sillence MN, Hackett LP. Pharmacokinetics of metformin after enteral administration in insulin-resistant ponies.. Am J Vet Res 2010 Oct;71(10):1201-6.
    doi: 10.2460/ajvr.71.10.1201pubmed: 20919907google scholar: lookup
  23. Hustace JL, Firshman AM, Mata JE. Pharmacokinetics and bioavailability of metformin in horses.. Am J Vet Res 2009 May;70(5):665-8.
    doi: 10.2460/ajvr.70.5.665pubmed: 19405907google scholar: lookup
  24. Smith S, Harris PA, Menzies-Gow NJ. Comparison of the in-feed glucose test and the oral sugar test.. Equine Vet J 2016 Mar;48(2):224-7.
    doi: 10.1111/evj.12413pubmed: 25582152google scholar: lookup
  25. Walters WA, Caporaso JG, Lauber CL, Berg-Lyons D, Fierer N, Knight R. PrimerProspector: de novo design and taxonomic analysis of barcoded polymerase chain reaction primers.. Bioinformatics 2011 Apr 15;27(8):1159-61.
    doi: 10.1093/bioinformatics/btr087pmc: PMC3072552pubmed: 21349862google scholar: lookup
  26. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample.. Proc Natl Acad Sci U S A 2011 Mar 15;108 Suppl 1(Suppl 1):4516-22.
    doi: 10.1073/pnas.1000080107pmc: PMC3063599pubmed: 20534432google scholar: lookup
  27. Loy A, Maixner F, Wagner M, Horn M. probeBase--an online resource for rRNA-targeted oligonucleotide probes: new features 2007.. Nucleic Acids Res 2007 Jan;35(Database issue):D800-4.
    doi: 10.1093/nar/gkl856pmc: PMC1669758pubmed: 17099228google scholar: lookup
  28. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads.. EMBnet J. 2011;17:10–12.
    doi: 10.14806/ej.17.1.200google scholar: lookup
  29. Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, Bai Y, Bisanz JE, Bittinger K, Brejnrod A, Brislawn CJ, Brown CT, Callahan BJ, Caraballo-Rodríguez AM, Chase J, Cope EK, Da Silva R, Diener C, Dorrestein PC, Douglas GM, Durall DM, Duvallet C, Edwardson CF, Ernst M, Estaki M, Fouquier J, Gauglitz JM, Gibbons SM, Gibson DL, Gonzalez A, Gorlick K, Guo J, Hillmann B, Holmes S, Holste H, Huttenhower C, Huttley GA, Janssen S, Jarmusch AK, Jiang L, Kaehler BD, Kang KB, Keefe CR, Keim P, Kelley ST, Knights D, Koester I, Kosciolek T, Kreps J, Langille MGI, Lee J, Ley R, Liu YX, Loftfield E, Lozupone C, Maher M, Marotz C, Martin BD, McDonald D, McIver LJ, Melnik AV, Metcalf JL, Morgan SC, Morton JT, Naimey AT, Navas-Molina JA, Nothias LF, Orchanian SB, Pearson T, Peoples SL, Petras D, Preuss ML, Pruesse E, Rasmussen LB, Rivers A, Robeson MS 2nd, Rosenthal P, Segata N, Shaffer M, Shiffer A, Sinha R, Song SJ, Spear JR, Swafford AD, Thompson LR, Torres PJ, Trinh P, Tripathi A, Turnbaugh PJ, Ul-Hasan S, van der Hooft JJJ, Vargas F, Vázquez-Baeza Y, Vogtmann E, von Hippel M, Walters W, Wan Y, Wang M, Warren J, Weber KC, Williamson CHD, Willis AD, Xu ZZ, Zaneveld JR, Zhang Y, Zhu Q, Knight R, Caporaso JG. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2.. Nat Biotechnol 2019 Aug;37(8):852-857.
    doi: 10.1038/s41587-019-0209-9pmc: PMC7015180pubmed: 31341288google scholar: lookup
  30. Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data.. Nat Methods 2016 Jul;13(7):581-3.
    doi: 10.1038/nmeth.3869pmc: PMC4927377pubmed: 27214047google scholar: lookup
  31. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glöckner FO. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools.. Nucleic Acids Res 2013 Jan;41(Database issue):D590-6.
    doi: 10.1093/nar/gks1219pmc: PMC3531112pubmed: 23193283google scholar: lookup
  32. Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation.. Nucleic Acids Res 2009 Jul;37(Web Server issue):W652-60.
    doi: 10.1093/nar/gkp356pmc: PMC2703878pubmed: 19429898google scholar: lookup
  33. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing.. J. R. Stat. Soc. Ser. B. 1995;57:289–300.
    doi: 10.1111/j.2517-6161.1995.tb02031.xgoogle scholar: lookup
  34. Hammer O, Harper DAT. PAST: Paleontological statistics software package for education and data analysis.. Palaeontol. Electron. 2011;4:1–9.
  35. Spring S, Bunk B, Spröer C, Schumann P, Rohde M, Tindall BJ, Klenk HP. Characterization of the first cultured representative of Verrucomicrobia subdivision 5 indicates the proposal of a novel phylum.. ISME J 2016 Dec;10(12):2801-2816.
    doi: 10.1038/ismej.2016.84pmc: PMC5148204pubmed: 27300277google scholar: lookup
  36. Hugenholtz P, Goebel BM, Pace NR. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity.. J Bacteriol 1998 Sep;180(18):4765-74.
    doi: 10.1128/JB.180.18.4765-4774.1998pmc: PMC107498pubmed: 9733676google scholar: lookup
  37. Shepherd ML, Swecker WS Jr, Jensen RV, Ponder MA. Characterization of the fecal bacteria communities of forage-fed horses by pyrosequencing of 16S rRNA V4 gene amplicons.. FEMS Microbiol Lett 2012 Jan;326(1):62-8.
    doi: 10.1111/j.1574-6968.2011.02434.xpubmed: 22092776google scholar: lookup
  38. Kuczynski J, Stombaugh J, Walters WA, González A, Caporaso JG, Knight R. Using QIIME to analyze 16S rRNA gene sequences from microbial communities.. Curr Protoc Bioinformatics 2011 Dec;Chapter 10:10.7.1-10.7.20.
    doi: 10.1002/0471250953.bi1007s36pmc: PMC3249058pubmed: 22161565google scholar: lookup
  39. Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E, Knight R, Huttley GA, Gregory Caporaso J. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2's q2-feature-classifier plugin.. Microbiome 2018 May 17;6(1):90.
    doi: 10.1186/s40168-018-0470-zpmc: PMC5956843pubmed: 29773078google scholar: lookup
  40. Willing B, Vörös A, Roos S, Jones C, Jansson A, Lindberg JE. Changes in faecal bacteria associated with concentrate and forage-only diets fed to horses in training.. Equine Vet J 2009 Dec;41(9):908-14.
    doi: 10.2746/042516409X447806pubmed: 20383990google scholar: lookup
  41. Daly K, Proudman CJ, Duncan SH, Flint HJ, Dyer J, Shirazi-Beechey SP. Alterations in microbiota and fermentation products in equine large intestine in response to dietary variation and intestinal disease.. Br J Nutr 2012 Apr;107(7):989-95.
    doi: 10.1017/S0007114511003825pubmed: 21816118google scholar: lookup
  42. Fernandes KA, Kittelmann S, Rogers CW, Gee EK, Bolwell CF, Bermingham EN, Thomas DG. Faecal microbiota of forage-fed horses in New Zealand and the population dynamics of microbial communities following dietary change.. PLoS One 2014;9(11):e112846.
    doi: 10.1371/journal.pone.0112846pmc: PMC4226576pubmed: 25383707google scholar: lookup
  43. Salem SE, Maddox TW, Berg A, Antczak P, Ketley JM, Williams NJ, Archer DC. Variation in faecal microbiota in a group of horses managed at pasture over a 12-month period.. Sci Rep 2018 May 31;8(1):8510.
    doi: 10.1038/s41598-018-26930-3pmc: PMC5981443pubmed: 29855517google scholar: lookup

Citations

This article has been cited 2 times.
  1. Weinert-Nelson JR, Biddle AS, Sampath H, Williams CA. Fecal Microbiota, Forage Nutrients, and Metabolic Responses of Horses Grazing Warm- and Cool-Season Grass Pastures.. Animals (Basel) 2023 Feb 22;13(5).
    doi: 10.3390/ani13050790pubmed: 36899650google scholar: lookup
  2. Weinert-Nelson JR, Biddle AS, Williams CA. Fecal microbiome of horses transitioning between warm-season and cool-season grass pasture within integrated rotational grazing systems.. Anim Microbiome 2022 Jun 21;4(1):41.
    doi: 10.1186/s42523-022-00192-xpubmed: 35729677google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.